Customize your JAMA Network experience by selecting one or more topics from the list below.
Hong HY, Karadaghy O, Kallogjeri D, et al. Effect of Nitrous Oxide as a Treatment for Subjective, Idiopathic, Nonpulsatile Bothersome Tinnitus: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2018;144(9):781–787. doi:10.1001/jamaoto.2018.1278
Can the administration of nitrous oxide reduce or eliminate bothersome tinnitus?
In this randomized clinical trial of 40 participants, the Tinnitus Functional Index after intervention was lower than before intervention in the placebo arm and in the nitrous oxide arm. The within-participant mean difference in the change in the Tinnitus Functional Index of the placebo arm compared with the nitrous oxide arm was −1.1 points, which was neither clinically or statistically significant.
Nitrous oxide is no more effective than placebo for the treatment of tinnitus.
The tinnitus research literature suggests that N-methyl-d-aspartate (NMDA) receptor antagonists may be useful in reducing tinnitus. Nitrous oxide, a member of the NMDA receptor antagonist class, is a widely used general anesthetic and sedative with a proven safety record.
To investigate whether nitrous oxide can reduce bothersome tinnitus.
Design, Setting, and Participants
Randomized, placebo-controlled crossover trial conducted between October 15, 2016, and June 22, 2017. Participants attended 2 interventional sessions separated by at least 14 days and were randomized to receive either placebo first or nitrous oxide first. Participants were followed up through completion of the second arm of the study. The setting was a clinical research unit at an academic medical center. Adults aged 18 to 65 years with subjective, idiopathic, nonpulsatile bothersome tinnitus of 6 months’ duration or longer were recruited from 2 clinical research databases. Seventy-one individuals were screened, of whom 40 were enrolled. Of those enrolled, 37 participants completed all components of the study.
The placebo session consisted of 50% nitrogen and 50% oxygen inhaled for 40 minutes, and the treatment session consisted of 50% nitrous oxide and 50% oxygen inhaled for 40 minutes.
Main Outcomes and Measures
Tinnitus was assessed before and after intervention, with the change in the Tinnitus Functional Index (TFI) as the primary outcome measure. Secondary outcome measures included the Patients’ Global Impression of Change score and the change in the Global Bothersome Scale score.
Among 40 participants in this intent-to-treat randomized clinical trial with 20 participants randomly assigned to each group, the mean (SD) age of participants was 52.9 (11.1) years, with equal numbers of male and female participants. The TFI after intervention was a mean (SD) of 1.8 (8.8) points lower than before intervention in the placebo arm and a mean (SD) of 2.5 (11.0) points lower than before intervention in the nitrous oxide arm. The within-participant mean difference in the change in the TFI of the placebo arm compared with the nitrous oxide arm was −1.1 points (95% CI, −5.6 to 3.4 points). The difference between the placebo and nitrous oxide arms was neither clinically meaningful nor statistically significant.
Conclusions and Relevance
Nitrous oxide was no more effective than placebo for the treatment of subjective, idiopathic tinnitus.
ClinicalTrials.gov identifier: NCT03365011
Create a personal account or sign in to: